Agilent Technologies, Inc. (NYSE:A) Shares Sold by Arjuna Capital

Arjuna Capital cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 46.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,813 shares of the medical research company’s stock after selling 9,231 shares during the period. Arjuna Capital’s holdings in Agilent Technologies were worth $1,606,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Crewe Advisors LLC raised its position in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Livelsberger Financial Advisory purchased a new stake in Agilent Technologies in the third quarter valued at approximately $28,000. Ridgewood Investments LLC purchased a new stake in Agilent Technologies in the second quarter valued at approximately $29,000. Ashton Thomas Securities LLC purchased a new stake in Agilent Technologies in the third quarter valued at approximately $31,000. Finally, Fortitude Family Office LLC increased its position in shares of Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after acquiring an additional 95 shares during the period.

Insider Buying and Selling

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 11,995 shares of company stock worth $1,739,510.

Agilent Technologies Price Performance

Agilent Technologies stock traded down $0.52 during mid-day trading on Wednesday, reaching $133.15. The company had a trading volume of 76,010 shares, compared to its average volume of 1,697,110. Agilent Technologies, Inc. has a 1 year low of $109.46 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The company has a market capitalization of $38.26 billion, a P/E ratio of 27.73, a P/E/G ratio of 5.89 and a beta of 1.07. The stock’s 50-day simple moving average is $139.17 and its 200-day simple moving average is $138.16.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the company posted $1.43 EPS. The company’s revenue was down 5.6% on a year-over-year basis. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were given a dividend of $0.236 per share. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a yield of 0.71%. Agilent Technologies’s dividend payout ratio (DPR) is currently 19.50%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on A shares. Bank of America upped their price objective on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. UBS Group increased their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and issued a $151.00 price objective on shares of Agilent Technologies in a research note on Monday, August 26th. TD Cowen upped their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Evercore ISI upped their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $144.36.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.